Latest Information Update: 02 Aug 2000
At a glance
- Originator Pfizer
- Class Antihypertensives
- Mechanism of Action Endothelin A receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Heart failure
Most Recent Events
- 02 Aug 2000 No-Development-Reported for Congestive heart failure in USA (Unknown route)
- 21 Jun 2000 Warner-Lambert has merged with Pfizer
- 06 Nov 1998 New profile